Long-form reading · Shared publisherMeet the Long-view Desk ↗
Metabolic
Care JournalMCJ / 01

The publication

The source record

Official pages, original research and clearly identified evidence limits.

Source notes

Checked October 5, 2026. Provider pages document advertised terms. Study summaries identify the scope of our review.

  1. NIDDK — talking with patients about weightRespectful, collaborative care guidance
  2. NIDDK — staying active at any sizeFederal patient education
  3. NIDDK — prescription medications for overweight and obesityTreatment and ongoing-care context
  4. FDA — compounding questions and answersRegulatory context
  5. FDA — concerns with unapproved GLP-1 drugsSafety and product context
  6. CoreAge Rx — semaglutideProvider offer
  7. CoreAge Rx — tirzepatideProvider offer
  8. CoreAge Rx — pricing and plansProvider terms
  9. SuperHealthy Rx — GLP-1 offerProvider promotion
  10. Likeness Rx — GLP-1 plansProvider terms
  11. WeightWatchers — Med+Provider membership offer
  12. Noom Med — pricingProvider pricing; branded pathway reviewed
  13. Noom — branded prescription pathwayProvider pharmacy and follow-up information
  14. Found — offer termsProvider terms; branded GLP-1 plan reviewed